# Cost-effectiveness of Four Immunomodulatory Therapies for Relapsing-Remitting Multiple Sclerosis: A Markov Model Based on Long-term Clinical Data

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-four-immunomodulatory-therapies-for-relapsing-remitting/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Christopher F. Bell,Jonathan Graham,Stephanie Earnshaw,MerriKay Oleen-Burkey,Jane Castelli‐Haley,Kenneth P. Johnson |
| Citations | 106 |
| DOI | 10.18553/jmcp.2007.13.3.245 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://pmc.ncbi.nlm.nih.gov/articles/PMC10438176/pdf/jmcp.2007.13.3.245.pdf |
| OpenAlex ID | https://openalex.org/W2134015462 |
| PMID | 17407391 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Christopher F. Bell](https://scholariq.org/researchers/christopher-f-bell/)

## Paper primary topic

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Paper topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.